Press Releases

MONMOUTH JUNCTION, N.J., Feb. 5, 2020 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ:CTSO), a critical care immunotherapy leader commercializing its

PARAMUS, N.J., Feb. 5, 2020 /PRNewswire/ -- Ichnos Sciences Inc. is pleased to announce that Gabriela Gruia, M.D. has assumed the role of Chief Development Officer, effective immediately. In this position, Gabriela will oversee several functions critical to advancing assets in the Ichnos pipeline, including regulatory sciences, clinical op

SAN FRANCISCO, Feb. 5, 2020 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced that it will report its fourth quarter and full year 2019

SUNNYVALE, Calif., Feb. 5, 2020 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that two new studies demonstrate the benefits of the TomoTherapy&r

SOUTH SAN FRANCISCO, Calif., Feb. 5, 2020 /PRNewswire/ -- Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create next-generation oncology therapeutics, today announced the expansion of its senior management team with the appo

HOUSTON, Feb. 5, 2020 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors, today announced it intends to discuss with the FDA and EMA (European Medicines Agency) plans to conduct a single arm Phase 2 trial that would ser

SOUTH SAN FRANCISCO, Calif., Feb. 5, 2020 /PRNewswire/ -- CODA Biotherapeutics, Inc., a preclinical-stage biopharmaceutical company developing a gene therapy-mediated chemogenetic platform, today announced it has completed the acquisition of Attenua, Inc. With the acquisition, CODA has obtained three small molecule drugs that have been shown to be safe and well tol

ST. LOUIS, Feb. 5, 2020 /PRNewswire/ -- Centene Corporation (NYSE: CNC) ("Centene" or the "Company") announced today that it has commenced an offering to sell $2,000,000,000 of senior notes due 2030 (the "Notes"), subject to market and other conditions.Centene intends to use the net proceeds from the offering of

CARLSBAD, Calif., Feb. 5, 2020 /PRNewswire/ -- Thermo Fisher Scientific today introduced a new next-generation sequencing (NGS)-based solution that enables reprod

MINNEAPOLIS, Feb. 5, 2020 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a global leader and the most cited manufacturer of immunoassay kits, announced the release of the Quantikine QuicKit™ ELISA product line. This next generation ELISA product line expands the capabilities of our legacy Quantikine® ELISA kits, enabling researchers to accomplish more